共 50 条
- [31] CHOLESTYRAMINE-ENHANCED FECAL ELIMINATION OF C-14 IN RATS AFTER ADMINISTRATION OF AMMONIUM [C-14] PERFLUOROOCTANOATE OR POTASSIUM [C-14]PERFLUOROOCTANESULFONATE FUNDAMENTAL AND APPLIED TOXICOLOGY, 1984, 4 (06): : 972 - 976
- [33] DISPOSITION AND METABOLISM OF (C-14) SPARFLOXACIN AFTER REPEATED ADMINISTRATION IN THE RAT ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1991, 41-2 (07): : 760 - 763
- [35] DISTRIBUTION AND EXCRETION OF C-14 LABELED PRISCOLINE-HC1 IN RATS JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1953, 109 (03): : 318 - 327
- [37] LEVEL OF CLODRONATE IN BONE AFTER SINGLE AND REPEATED SUBCUTANEOUS INJECTIONS IN RATS PHARMACOLOGY & TOXICOLOGY, 1991, 69 (05): : 369 - 371
- [38] EFFECT OF DIETARY FAT ON EXCRETION AND DEPOSITION OF C-14 FROM CHOLESTEROL-4-C-14 IN RATS PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1959, 102 (01): : 155 - 157
- [39] PHARMACOKINETICS OF NISOLDIPINE .1. ABSORPTION, CONCENTRATION IN PLASMA, AND EXCRETION AFTER SINGLE ADMINISTRATION OF [C-14]NISOLDIPINE IN RATS, DOGS, MONKEY, AND SWINE ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-2 (08): : 1093 - 1098